Sepetaprost demonstrated noninferiority to timolol 0.5% in decreasing intraocular pressure for patients with glaucoma or ocular hypertension.

Marshall, a constitutional law professor at John Jay College of Criminal Justice, said protestors need to brace themselves ...

World Bank President Ajay S. Banga said global development initiatives must prioritize job creation at a Harvard Institute of ...

DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...

Glaucoma can cause irreversible vision loss that affects up to an estimated 3% of the population over 40 years of age. The current pharmacotherapy primarily aims to manage only intraocular pressure ...

With a new measurement imminent, the Courier explores the experimental results and theoretical calculations used to predict ...

What better way to communicate accelerator physics to the public than using a functioning particle accelerator?

The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: pegcetacoplan, or Syfovre, from Apellis Pharmaceuticals and avacincaptad pegol ...

A group called Safer Hinsdale has been texting residents, posting on social media, sending a mailing and inviting residents ...

The investigators conducted a prospective interventional study to determine the therapeutic anatomic and functional effects ...